Related Experiment Video
Updated: Sep 17, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Prognostic significance of mild ascites in patients with cirrhosis
Nicolas Chong Lugon1,2, Anahita Rabiee1,2, Catherine Mezzacappa1,2
1Digestive Diseases Section, VA Connecticut Healthcare System, West Haven, Connecticut, USA.
Background And Aims:
Overt (clinically detectable) ascites is the most common decompensating event in cirrhosis and is associated with a high mortality. The impact of mild ascites (only detectable by imaging) remains unclear.
Approach And Results:
Retrospective cohort study in patients with cirrhosis using the Veterans Outcomes and Costs Associated with Liver Disease (VOCAL) cohort. Imaging reports at the time of diagnosis of cirrhosis were analyzed using natural language processing and classified into 3 groups: no ascites, grade 1 (G1) or mild ascites, and grade 2/3 (G2/G3) or overt ascites. Mortality was compared across the groups using the Kaplan-Meier method and multivariable Cox proportional hazards analysis. A total of 41,699 patients were included in the study: 28,628 (68.7%) without ascites, 4046 (9.7%) with G1, and 6268 (15.0%) with G2/G3 ascites. Median follow-up time was 7.7 years (IQR 5.1-10.6). In patients with G1 (mild) ascites, median survival was 3.9 years (IQR 1.8-8.3), significantly lower than in those without ascites (6.5 years; IQR 3.1-12.2, p <0.0001) but significantly higher than in those with G2/G3 ascites (3.5 years; IQR 1.5-7.9, p <0.0001). After adjusting for potential confounders, the presence of any grade of ascites was associated with a higher hazard of mortality: G1 ascites (HR 1.50; 95% CI 1.44-1.57, p <0.001) and G2/G3 ascites (HR 1.63; 95% CI 1.57-1.69, p <0.001). These results were consistent across multiple sensitivity analyses.
Conclusions:
Grade 1 (mild or subclinical) ascites is associated with poorer survival compared with no ascites and represents an intermediate prognostic stage between compensated and decompensated cirrhosis.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

